ARCHIVES

Study: BRCA2-Negative Women Could Still Have High Risk

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Amgen Pays $24.9 Million To Settle Kickback Charges

April 19, 2013

DCE Publishes Lister of Resources Available To Scientific Community

November 9, 1984

Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall

June 5, 2009

Lower Dose Dexamethasone Can Be Used To Treat Newly Diagnosed Myeloma

November 27, 2009

CSR Draft Report Proposes New Panel To Review Clinical Oncology Research

February 20, 1998

In Brief: Weldon Gage named CFO at MD Anderson Cancer Center

December 12, 2014